The therapeutic effect of ofatumumab in pediatric anti-NMDAR encephalitis: A case series

The therapeutic effect of ofatumumab in pediatric anti-NMDAR encephalitis: A case series

Ofatumumab (OFA) is an anti-CD20 antibody. We assessed the therapeutic potential of OFA in five pediatric anti-NMDAR encephalitis patients who showed poor responses to the first-line immunotherapy. OFA treatment showed clinical improvement including alleviation of clinical symptoms and mRS decrease...

Full description

Bibliographic Details
Main Authors: Wenlin Wu, Jie Hong, Yanping Ran, Wenxiao Wu, Haixia Zhu, Chi Hou, Yuanyuan Gao, Yulin Tang, Yinting Liao, Wen-Xiong Chen, Xiaojing Li
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Heliyon
Subjects:
Refractory
Anti-NMDAR encephalitis
Children
Ofatumumab
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024167114

Internet

http://www.sciencedirect.com/science/article/pii/S2405844024167114

Similar Items